IRAK1BP1 (interleukin 1 receptor associated kinase 1 binding protein 1) is a regulatory protein that plays a critical role in controlling toll-like receptor (TLR)-mediated inflammatory responses. Located on chromosome 6, IRAK1BP1 functions as a negative regulator of TLR signaling, acting to prevent excessive production of pro-inflammatory cytokines 1. The protein enhances NF-κB signaling through the TNFRSF1A pathway by promoting RELA transcriptional activity, yet paradoxically exhibits antiinflammatory effects by selectively suppressing transcription of specific TLR-responsive genes 1. This regulatory function is particularly important in protecting against dangerous overproduction of interleukin-6 and other inflammatory mediators during innate immune activation 1. Epigenetic modifications of IRAK1BP1 have clinical significance in inflammatory diseases. DNA methylation patterns of IRAK1BP1 vary with periodontitis severity—hypermethylation occurs in early disease stages while hypomethylation characterizes advanced periodontitis 23. In cardiovascular disease, IRAK1BP1 expression is reduced in subordinate primates with increased atherosclerosis risk 4. Additionally, IRAK1BP1 genetic variants associate with blood pressure responses to dietary interventions and hypertension development 5. Endocannabinoids modulate IRAK1BP1 levels to suppress HIV-1 Tat-induced inflammation in retinal tissue 67, suggesting therapeutic potential. IRAK1BP1 also participates in TNF-α-induced NF-κB activation in bone marrow mesenchymal stem cells 8.